Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Irie

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Cancer Research|July 15, 1989
An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapyM H Ravindranath, D L Morton, R F Irie
Human Antibodies and Hybridomas|January 1, 1994
Serum preparation and methods for the large-scale production of IgG monoclonal antibodyQ S Zeng, H Takeyama, S Kanda, et al.
Breast Cancer Research and Treatment|June 16, 1999
Recognition of an epitope of a breast cancer antigen by human antibodyJ Cao, T Gao, A E Giuliano, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1986
Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograftM Katano, R E Saxton, T Tsuchida, et al.
British Journal of Cancer|September 25, 1999
Cytotoxic T lymphocytes that recognize decameric peptide sequences of retinoblastoma binding protein 1 (RBP-1) associated with human breast cancerT Takahashi, J Cao, D S Hoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanomaT Takahashi, R F Irie, Y Nishinaka, et al.
Tissue Antigens|March 1, 1978
A new heterophile antigen: man distinguished from higher apes and other mammalsR F Irie, K Irie, E J Shaw, et al.
Cancer Research|March 1, 1987
Gangliosides of human melanoma: altered expression in vivo and in vitroT Tsuchida, M H Ravindranath, R E Saxton, et al.
Cancer|June 15, 1991
Ganglioside GM3:GD3 ratio as an index for the management of melanomaM H Ravindranath, T Tsuchida, D L Morton, et al.
Cellular Immunology|June 15, 1997
Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patientsT Takahashi, R F Irie, D L Morton, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Cancer Research|July 15, 1989
An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapyM H Ravindranath, D L Morton, R F Irie
Human Antibodies and Hybridomas|January 1, 1994
Serum preparation and methods for the large-scale production of IgG monoclonal antibodyQ S Zeng, H Takeyama, S Kanda, et al.
Breast Cancer Research and Treatment|June 16, 1999
Recognition of an epitope of a breast cancer antigen by human antibodyJ Cao, T Gao, A E Giuliano, et al.
Japanese Journal of Cancer Research : Gann|June 1, 1986
Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograftM Katano, R E Saxton, T Tsuchida, et al.
British Journal of Cancer|September 25, 1999
Cytotoxic T lymphocytes that recognize decameric peptide sequences of retinoblastoma binding protein 1 (RBP-1) associated with human breast cancerT Takahashi, J Cao, D S Hoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanomaT Takahashi, R F Irie, Y Nishinaka, et al.
Tissue Antigens|March 1, 1978
A new heterophile antigen: man distinguished from higher apes and other mammalsR F Irie, K Irie, E J Shaw, et al.
Cancer Research|March 1, 1987
Gangliosides of human melanoma: altered expression in vivo and in vitroT Tsuchida, M H Ravindranath, R E Saxton, et al.
Cancer|June 15, 1991
Ganglioside GM3:GD3 ratio as an index for the management of melanomaM H Ravindranath, T Tsuchida, D L Morton, et al.
Cellular Immunology|June 15, 1997
Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patientsT Takahashi, R F Irie, D L Morton, et al.
Pageof 8